Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS30016336HIVENSG00000072571.20protein_codingHMMRNoNo3161O75330
TVIS30016337HIVENSG00000072571.20protein_codingHMMRNoNo3161O75330
TVIS30063909HIVENSG00000072571.20protein_codingHMMRNoNo3161O75330
TVIS30063910HIVENSG00000072571.20protein_codingHMMRNoNo3161O75330
TVIS30063911HIVENSG00000072571.20protein_codingHMMRNoNo3161O75330
TVIS30063912HIVENSG00000072571.20protein_codingHMMRNoNo3161O75330
TVIS20001854HPVENSG00000072571.20protein_codingHMMRNoNo3161O75330
TVIS20040856HPVENSG00000072571.20protein_codingHMMRNoNo3161O75330
TVIS20030656HPVENSG00000072571.20protein_codingHMMRNoNo3161O75330
TCGA Plot Options
Drug Information
GeneHMMR
DrugBank IDDB08818
Drug NameHyaluronic acid
Target IDBE0004702
UniProt IDO75330
Regulation Typebinder
PubMed IDs21947782; 31294035; 21914806
CitationsHatano H, Shigeishi H, Kudo Y, Higashikawa K, Tobiume K, Takata T, Kamata N: Overexpression of receptor for hyaluronan-mediated motility (RHAMM) in MC3T3-E1 cells induces proliferation and differentiation through phosphorylation of ERK1/2. J Bone Miner Metab. 2012 May;30(3):293-303. doi: 10.1007/s00774-011-0318-0. Epub 2011 Sep 27.@@Gupta RC, Lall R, Srivastava A, Sinha A: Hyaluronic Acid: Molecular Mechanisms and Therapeutic Trajectory. Front Vet Sci. 2019 Jun 25;6:192. doi: 10.3389/fvets.2019.00192. eCollection 2019.@@Kouvidi K, Berdiaki A, Nikitovic D, Katonis P, Afratis N, Hascall VC, Karamanos NK, Tzanakakis GN: Role of receptor for hyaluronic acid-mediated motility (RHAMM) in low molecular weight hyaluronan (LMWHA)-mediated fibrosarcoma cell adhesion. J Biol Chem. 2011 Nov 4;286(44):38509-20. doi: 10.1074/jbc.M111.275875. Epub 2011 Sep 13.
GroupsApproved; Vet_approved
Direct ClassificationAcylaminosugars
SMILESCC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)C1O[C@@H]1O[C@@H]([C@@H](O[C@@H]2O[C@H](CO)[C@@H](O)C(O[C@@H]3O[C@@H]([C@@H](O)[C@H](O)[C@H]3O)C(O)=O)[C@H]2NC(C)=O)[C@H](O)[C@H]1O)C(O)=O
Pathways
PharmGKBPA165958431
ChEMBL